SANUWAVE HEALTH, INC.
Last · NasdaqGM$5.14-0.47 (-8.38%)close · yahoo · 19h ago
1Y price · close
$5.14— 1y$5.14
Market cap$44.22M8.6M sh
P/E · TTM23.4fwd -514 · eps 0.22
Beta1.42vs S&P 500
Div yield0.00%annual · TTM
52w range
$3.92$36.42
Volume49.7Ksession
| Revenue | $44.1M |
|---|---|
| Operating income | $4.9M |
| Net income | $11.8M |
| Free cash flow | $1.9M |
| Operating margin | 11.2% |
| Net margin | 26.8% |
| Return on equity | 729.6% |
| Period | 2025 |
Loading chart…
OpenFilings analyst
Our analyst
From latest 10-K · 2026-03-26
- Accumulated Deficit High
Red flags
- Accumulated Deficit High — Accumulated deficit / equity 14990%
Upcoming earnings
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
—
Est. revenue
0
Earnings transcripts
Press & signals
- GlobeNewswire
Sanuwave Announces Q2 FY2026 Financial Results
- GlobeNewswire
Sanuwave Health Reports Preliminary Q2 2026 Revenue of $9.6–$9.8 Million, Above High End of Revised Guidance